海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
261件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- The bone effects of pioglitazone
- Type 2 diabetes mellitus;Osteoporosis
- New Zealand
- 2007-11-28
Not recruiting
- A Randomized, Placebo-controlled Study Investigating the Effects of Moxaverine on Ocular Blood Flow After Oral Administration in Healthy Subjects
- Effect of Orally Administrated Moxaverine on Ocular Blood Flow
- Austria
- 2012-06-11
Not Recruiting
- Oral administration of maternal bacteria in twins born by C-section
- Abnormal gut microbiota in infants born by C-section; Abnormal gut microbiota in infants born by C-section;Metabolic and Endocrine - Metabolic disorders;Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon
- New Zealand
- 2018-03-06
Not Recruiting
- A randomized, placebo-controlled study investigating the effects of moxaverine on ocular blood flow after oral administration in healthy subjects - MOXOPH3
- healthy subjects MedDRA version: 12.1 Level: LLT Classification code 10038881 Term: Retinal microcirculation disorder MedDRA version: 12.1 Level: HLT Classification code 10030067 Term: Ocular vascular disorders NEC
- Austria
- 2010-04-08
Not Recruiting
- Influence of the PPAR gamma -agonist Pioglitazone on endothelial function in the peripheral and myocardial vascular territories and on myocardial efficiency in obese subjects - Pioglitazone
- There is an association between insulin resistance and endothelial dysfunction which is thought to be a critical factor in the development of vascular disease and thus an important factor in the development of atherosclerosis, hypertension and heart failure. Endothelial dysfunction can occur even in the vascular absence of angiographically defined disease and can be detected early in the spectrum of insulin resistance.
- Austria
- 2005-04-05
Not recruiting
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7020322 Following Oral Administration in Healthy Participants and Chronic Hepatitis B Patients
- Hepatitis B, Chronic;Hepatitis B, Chronic;Hepatitis B, Chronic;Hepatitis B, Chronic
- Hong Kong, New Zealand, Taiwan
- 2015-11-10
Recruiting
- Observational Study of Adult Patients Receiving Dupixent® for Atopic Dermatitis (AD)
- Dermatitis Atopic
- Austria
- 2019-06-18
Authorised
- To evaluate the efficacy and safety of CNP520 in participants at risk for the onset of clinical symptoms of Alzheimer’s Disease (AD)
- Alzheimer's disease MedDRA version: 19.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Argentina, Austria, Belgium, Canada, Chile, China, Finland, France, Germany, Hong Kong, Iceland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Singapore, South Africa, Spain, Taiwan, United Kingdom, United States
- 2017-03-31
Not recruiting
- Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone
- Mycobacterium Infections, Nontuberculous;Mycobacterium Infections, Nontuberculous;Mycobacterium Infections, Nontuberculous
- Australia, Austria, Canada, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, New Zealand, Poland, Spain, Sweden, Taiwan, Thailand, United Kingdom, United States
- 2015-01-09
Not recruiting
- Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 Diabetes
- Diabetes Mellitus
- Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Italy, Latvia, Lithuania, Netherlands, Norway, Poland, Slovakia, Sweden, Switzerland, United Kingdom
- 2005-09-09
